Tumor vaccine development from dendritic cell-tumor cell fusions
- Detailed Technology Description
- None
- *Abstract
-
Heat shock protein 70 (HSP70) peptide complexes derived from the fusion of dendritic cells and tumor cells are superior cancer vaccines than HSP70 peptide complexes from tumor cells alone.
- Country/Region
- USA
For more information, please click Here

